| Literature DB >> 29626430 |
Alex M Ebied1, Rhonda M Cooper-DeHoff2.
Abstract
In 2017, the US Food and Drug Administration approved 46 novel drugs, and 29 drugs received newly approved indications. This record setting year was due in part to the new expedited review pathways. A review of these drugs is summarized.Keywords: Accelerated approval; FDA; Fast track; New indication; Novel drugs; Priority review
Mesh：
Year: 2018 PMID： 29626430 DOI： 10.1016/j.amjmed.2018.02.034
Source DB: PubMed Journal: Am J Med ISSN： 0002-9343 Impact factor: 4.965